Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises lonodelestat (POL6014) to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil that treats congenital muscular dystrophies. The company also out-licenses outside North America and France rights to its approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland. Show More...
-
Website https://www.santhera.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 13.04 CHF
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CHF -3.08 -7.6 -8.55 -1.55 -1.69 1.08 -5.65 -8.22 -7.86 -1.73 -1.73 Dividends CHF Payout Ratio % * Shares Mil 4.0 4.0 4.0 4.0 5.0 5.0 6.0 6.0 7.0 11.0 11.0 Book Value Per Share * CHF 18.38 14.87 10.17 2.31 1.36 1.9 14.21 8.79 0.45 0.83 1.91 Free Cash Flow Per Share * CHF -3.87 -1.13 -4.31 -2.19 -1.37 -2.17 -4.76 -5.36 -6.69 -6.18 Return on Assets % -12.98 -42.57 -89.44 -41.08 -46.11 8.49 -34.06 -51.39 -49.24 -16.84 -16.84 Financial Leverage (Average) 1.13 1.21 1.56 1.37 1.33 1.1 1.22 3.4 3.96 5.41 5.41 Return on Equity % -14.7 -49.44 -114.95 -61.11 -61.9 9.64 -39.22 -96.68 -180.36 -77.32 -77.32 Return on Invested Capital % -10.74 -47.04 -106.08 -54.55 -61.87 9.65 -39.21 -45.7 -60.2 -17.0 -17.0 Interest Coverage -0.55 -6.51 -249.33 -273.29 267.73 -12.34 -10.97 -2.02 -2.02 Current Ratio 9.06 4.68 4.48 3.3 6.12 12.08 6.08 5.85 2.18 2.06 2.06 Quick Ratio 8.44 4.24 4.37 3.09 5.96 11.28 5.19 4.71 1.39 1.53 1.53 Debt/Equity 0.03 0.05 0.19 1.65 1.96 2.77 2.77